Admission Date:  [**2173-5-31**]              Discharge Date:   [**2173-6-9**]  Date of Birth:  [**2135-11-15**]             Sex:   F  Service: MEDICINE  Allergies: Prochlorperazine  Attending:[**First Name3 (LF) 3918**] Chief Complaint: Cough, SOB  Major Surgical or Invasive Procedure: None  History of Present Illness: 37 year old female with a history of ALL, s/p allo SCT [**1-13**] c/b neutropenic fever and skin GVHD, presents with one day of shortness of breath and cough.
Patient has had a chronic cough for several months.
She also had some mild GGO on prior CTs, followed monthly, stable from [**Month (only) 404**] through [**2173-4-16**].
She felt progressively fatigued throughout the day.
She presented to oncology clinic where she was found to have a fever of 100.4.
Blood cultures were drawn, nasal swab sent for viral screen, and she was given cefepime IV 2g and admitted for fever.
Past Medical History: - Allogenic Double Cord Blood SCT on [**2173-1-11**], course complicated by neutropenic fever and acute skin GVHD.
- ALL - Asthma - HTN - Cervical Intraepithelial neoplasia - C-section in [**2165**] - Cardiomyopathy due to early anthracycline-related cardiotoxicity 9/[**2172**].
PAST ONCOLOGIC HISTORY:  Presented to ED with right chest and right upper extremity pain  and paresthesias and visual blurriness.
Leukapheresis --> WBC 35,000.
-Special Stains: MPO-negative, PAS-positive with cytoplasmic granular pattern.
--FISH: Ph-negative, abnormal pattern in 60/100 cells indicative of trisomy 22, abnormal MLL rearrangement in 90/100 cells INDUCTION: Phase I, weeks [**2-8**], day 1 = [**2172-8-13**] Daunorubicin 60 mg/m2 iv day 1, 8, 15 and 22 Vincristine 1.4 mg/m2 iv day 1, 8, 15 and 22 Dexamethasone 10 mg iv tid day [**3-4**] L-Asparaginase 10,000 IU day 17-28 MTX 12.5 mg IT day 8 (instead of day 15) -CSF = rare atypical mononuclear cells, favor atypical lymphocytes.
Cytarabine 75 mg/m2 = 130 mg IV Days [**2-8**], [**9-15**], 15-18, 22-25 Mercaptopurine 60 mg/m2 = 100 mg Day [**3-4**] MTX 12.5 mg IT Days 1, 8, 15, 22 Response Evaluation: Bone Marrow Aspirate/Biopsy on [**10-26**] CR: -No morphologic evidence of residual leukemia -Normal cytogenetics, negative FISH for MLL Intensification Therapy 3 cycles of HD-MTX 3 g/m2 days 1 ([**11-26**]-given), 8, and 22 Standard Leucovorin rescue L-asparaginase 10,000 IU days 2 ([**11-27**]-given,) 9, and 23 Allogenic Double Cord Blood SCT Conditioning was achieved with Fludarabine, and Ara-C and TBI.
Course complicated by neutropenic fever and acute skin GVHD.
NO MICROORGANISMS SEEN.
SENSITIVITIES: MIC expressed in MCG/ML  _________________________________________________________                              PSEUDOMONAS AERUGINOSA                              | CEFEPIME--------------   <=1 S CEFTAZIDIME-----------     2 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------   <=1 S MEROPENEM-------------<=0.25 S PIPERACILLIN/TAZO-----     8 S TOBRAMYCIN------------   <=1 S     LEGIONELLA CULTURE (Final [**2173-6-8**]):    NO LEGIONELLA ISOLATED.
NO FUNGAL ELEMENTS SEEN.
Immunoflourescent test for Pneumocystis jirovecii (carinii) (Final       [**2173-6-1**]):    NEGATIVE for Pneumocystis jirovecii (carinii)..     FUNGAL CULTURE (Final [**2173-6-17**]):    NO FUNGUS ISOLATED.
Cytology from BAL:    NEGATIVE FOR MALIGNANT CELLS.
Note: No viral inclusions or fungal forms seen by routine   stain.
No evidence of pulmonary embolism.
Extensive bilateral alveolar opacities, the pattern suggests generalized infection, PCP and bacteria should be included in the differential diagnosis.
Small bilateral pleural effusions.
Mild pericardial effusion.
Two small splenules, borderline size of the left adrenal.
Extensive bilateral alveolar opacities are concerning for generalized infectious process.
PCP and bacterial pneumonia are included in the differential diagnosis.
Bilateral small pleural effusions.
Pseudomonas PNA - On admission, was believed to be a likely infectious process given fever, hypoxia and productive cough.
She has a h/o GGO opacities with multiple infections in the past.
Upon admission to the floor, she was transferred to the MICU for ongoing respiratory distress and urgent bronchoscopy with extensive infiltrates seen on CT Chest.
In the MICU, the patient was transiently on caspofungin, given that she had been on voriconazole for prophylaxis.
She improved overnight with decreased O2 requirement and, on the day following her transfer to the [**Hospital Unit Name 153**], she was transferred back to the floor.
She was switched to a combination of Cefepime and Ciprofloxacin for double Abx coverage for Pseudomonas.
The patient continued to show significant symptomatic improvement over the next several days, with no further fevers and no longer had an oxygen requirement.
VISION CHANGES: description of blurry vision on admission, incideous in onset, was initially concerning for fungal or intracranial process while the patient was in MICU.
However, the symptoms resolved shortly thereafter.
The headache on admission was consistent with migraine HA.
No meningismus.
Not related to vision changes temporally.
The symptoms resolved by hospital day 3 and the patient remained free of headaches.
CHRONIC SYSTOLIC CHF: no signs of acute exacerbation or change in baseline status.
GERD: reports occoasional symptoms for which she takes omeprazole daily, which was continued while in hospital  Medications on Admission: acyclovir 400mg PO tid atovaquone 1500mg PO daily enzonatate 100mg PO tid carvedilol 37.5 mg PO bid advair 500/50 INH [**Hospital1 **] Folic Acid 1mg PO daily Cellcept 250mg PO bid Omeprazole 20mg PO daily Prednisone 10mg PO daily Tacrolimus 0.25mg PO bid Voriconazole 200mg PO q 12 Mag Oxide 133mg PO tid MVI 1 tab daily   Discharge Medications: 1.
Disp:*1 disk* Refills:*2*   Discharge Disposition: Home With Service  Facility: Critical Care Systems  Discharge Diagnosis: Primary: pneumonia  Secondary: ALL status post allogeneic stem cell trasnplant   Discharge Condition: Mental Status: Clear and coherent.
Discharge Instructions: You were admitted to the hospital because you developed shortness of breath, cough, fevers, and were found to have a pneumonia.
We gave you appropriate antibiotics and your symptoms improved.
At this time, you no longer require oxygen and are able to walk without getting short of breath.
Please call BMT fellow on call or come back to the hospital right away if you develop fevers, worsening cough, shortness of breath, nasal congestion, or any other concerning symptoms.
